L'Azienda ospedaliero-universitaria Careggi è il più grande ospedale policlinico di Firenze, uno dei principali in Italia, situato nell'area di Careggi, nella parte nord della città.

During the past decade, Azienda Ospedaliero-Universitaria Careggi conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 12 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 7 clinical trials were completed. i.e. 17.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliero-Universitaria Careggi" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Careggi Hospital" with 9 trials sponsored, "Azienda Ospedaliero-Universitaria Careggi" with 6 trials sponsored, "University of Florence" with 5 trials sponsored and "David Antoniucci" with 5 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliero-Universitaria Careggi" #1 collaborator was "University of Florence" with 5 trials as a collaborator, "A.R. CARD Onlus Foundation" with 3 trials as a collaborator, "Careggi Hospital" with 3 trials as a collaborator, "Azienda Ospedaliero-Universitaria Careggi" with 2 trials as a collaborator and "Cardiovascular Research Foundation, New York" with 2 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliero-Universitaria Careggi" are "Breast Cancer" (5 trials), "Critical Illness" (5 trials), "Acute Kidney Injury" (4 trials), "Surgery" (4 trials) and "Acute Coronary Syndrome" (3 trials). Many other conditions were trialed in "Azienda Ospedaliero-Universitaria Careggi" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliero-Universitaria Careggi" are "Drug" (46 trials), "Device" (16 trials), "Procedure" (10 trials), "Other" (9 trials) and "Diagnostic Test" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Etrolizumab" (3 trials), "Rituximab" (3 trials), "Commercial membrane for Extracorporeal Blood Purification Therapy (EBPT)" (2 trials) and "Crovalimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliero-Universitaria Careggi" are 84 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Azienda Ospedaliero-Universitaria Careggi". undefined are not yet recruiting, 34 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Azienda Ospedaliero-Universitaria Careggi, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliero-Universitaria Careggi, 4 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 14 trials that are defined as “Not Applicable".